Lift Toronto 2023 Cannabis Conference & Expo Connects Brands, Investors, Growers & Consumers from Across the Cannabis Industry

Cannabis industry growers, processors, manufacturers, brands, budtenders, retailers, educators, advocates, regulators, consumers, investors, and more, are invited to attend the Lift Toronto 2023 Cannabis Conference & Expo to be held June 1-3, 2023, at the Metro Toronto Convention Centre.

The three-day event will begin on Thursday, June 1, with the Lift Cannabis Business Conference (“LCBC”), an all-business strategy forum focused on generating meaningful change and sustainable growth within the Canadian cannabis industry. The conference will focus on the drivers of forward momentum, overcoming systemic challenges, and advancing innovative business and regulatory solutions. The LCBC sessions will include highlights such as keynotes and spotlight presenters, Canadian brands, world-view leadership panels, and more. Speakers will include industry leaders like Anna-Sophia Kouparanis, Co-Founder of the Bloomwell Group (Germany), Katy Perry, CEO of TOKE Cannabis, David Goldstein, CEO of Stoke Inventory Partners, and more.

“We are really pushing the envelope for our next trip to Toronto with top-tier presenters on red hot topics. Each session has been carefully curated to energize, inspire, educate, and motivate all of our audiences from across the entire cannabis community,” said Barry Smith, Canadian Content Director of Lift Events and Experiences.

Days two and three of the event will be Industry and Budtender Days and Consumer Day, respectively, at The Lift Expo tradeshow. Showcasing hundreds of leading and emerging exhibitors, the expo will also debut fresh experiences and activations, including games, photo opportunities, culinary cannabis trends, comedy performances, music, drinks, and more. In addition, multiple speakers, presentations, and panels on each of these two days will be featured on several stages placed throughout the expo floor. From the Main Stage to the East and West Speakers’ Corner Stages, carefully crafted content will inform and spark conversations that will drive the industry forward in the coming year.

Registration for the event is now open, with ‘early bird’ pricing available for a limited time. For more information on tickets and pricing, visit https://liftexpo.ca/tickets-toronto-2023/.

For more information on Lift Toronto 2023 and other Lift events, please visit https://liftevents.com/. Cannabis Education Conferences & Exhibitions | Lift Events & Experiences (liftexpo.ca)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — New Bipartisan Bill to Seal Federal Cannabis Records Automatically

Bipartisan congressional legislators have reintroduced a measure mandating the automatic sealing of records for nonviolent federal cannabis convictions. The bill would also offer relief to individuals who’d been arrested for other offenses that didn’t end in conviction.

Representatives Nancy Mace and Lisa Blunt Rochester filed the Clean Slate Act last week. The previous version of the bill was advanced through the House Judiciary Committee in 2022 but was never voted on.

In a press release, Blunt Rochester stated that the Clean Slate Act was one of her top priorities, highlighting the importance of giving those who had paid their debt to society and served their time a second chance and a clean slate. Blunt Rochester added that she looked forward to working with her colleagues across the aisle and Congress to approve the bill and advance it to the president’s desk.

The measure would also set up a new process for individuals to petition the courts to seal records for nonviolent offenses that weren’t eligible for automatic sealing. If their initial request was denied, individuals could still petition for relief once a two-year wait period was over. Additionally, district courts will be allowed to nominate a public defender to help petitioners process their record sealing requests.

Mace stated that this measure was an important step in the right direction because it focused on rehabilitation and second chances.

Last year, President Joseph Biden issued a mass pardon for individuals who had committed federal marijuana possession offenses. However, this proclamation is limited, as presidential pardons don’t help seal conviction records.

The Mace measure is supported by various institutions, including R Street, the American Conservative Union, LinkedIn, Brennan Center for Justice, Justice Action Network (JAN), Center for American Progress, JPMorgan Chase, Code for America and Clean Slate Initiative.

Nan Gibson, the executive director of the JPMorgan Chase Policy Center, stated that the bill would establish a process for clearing nonviolent federal records and streamline it via automation, helping individuals pursue stable career opportunities. Gibson then noted that this bill would allow companies such as JPMorgan Chase to continue connecting people to meaningful career pathways, strengthening the economy and uplifting communities.

The Clean Slate Initiative CEO Sheena Meade stated that Congress had the power to unlock opportunities for millions of individuals in the country by approving the Clean Slate Act.

This bill is the latest in a string of cannabis reform measures that have been introduced in Congress.

While many reforms have been put before Congress over the past years, not many have made their way through the legislative chambers and reached the president’s desk for enactment. This slow pace at which marijuana policy is reformed could soon accelerate if many companies such as IGC Pharma Inc. (NYSE American: IGC) are successful in seeing cannabis-based medicines through the clinical development process resulting in FDA approval. Such drugs could cause people to reconsider their perceptions about marijuana and a lot more pressure for reform could be exerted on federal lawmakers.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Washington Governor Enacts Bill Authorizing Cannabis Interstate Commerce

Washington State’s governor has signed legislation allowing interstate marijuana trade in anticipation of a change in federal law. Governor Jay Inslee recently signed the bill introduced by Senator Ann Rivers into law after it passed the legislature last month.

Prior to approving the legislation, Inslee pushed Congress to update the country’s cannabis laws, arguing that legalization at the federal level would support the competitiveness of the highly regulated marijuana market while also upholding health and public safety requirements.

Once a federal law is changed or a federal Justice Department decision authorizing cannabis trading across state lines is passed, the legislation will permit the state to engage in interstate cannabis trade.

Now that this bill has been approved, all three states on the western coastline are ready to allow cannabis export and import. Oregon passed its bill in 2019 while California followed suit last year.

The Washington legislation stipulates that if one of the two federal conditions is satisfied, state authorities must provide written notice of the policy change and any state-level statutory amendments necessary to allow the delivery, sale and reception of marijuana from businesses out of the state. However, under California law, implementation could also begin without taking into account any conditions at the federal level.

Regulators in Washington will also be required to develop rules that will guide marijuana exports and imports. However, the governor will have sole authority to sign agreements with other states. Goods imported from out-of-state businesses would have to abide by Washington regulations, including labeling and packaging guidelines.

Meanwhile, a legislator from Maine has introduced a bill to permit marijuana exports and imports between states where it is legal. A comparable interstate plan was submitted by New Jersey’s senate president last year, but it hasn’t yet been approved.

Additionally, last year, a federal court ruled that the U.S. Constitution’s Commerce Clause made Maine’s law prohibiting nonresidents from running medicinal cannabis businesses in the state unlawful. Some commentators contend that the same logic used to support the residency restrictions also applies to state-level restrictions on marijuana import and export, rendering them invalid. There is also a belief that prohibiting medicinal cannabis imports and exports in states that have legalized it would be seen as both unconstitutional and protectionist.

A marijuana company from Oregon sued in a national court in November, claiming that the state’s current prohibition on interstate marijuana imports and exports is unconstitutional.

If cannabis interstate commerce becomes a reality around the country, states with favorable cultivation conditions could have a competitive edge and perhaps opt to use equipment such the microgardens sold by Advanced Container Technologies Inc. (OTC: ACTX) to produce more cost effectively and sell to states where climate and other conditions make it harder for marijuana to be grown.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Completion of cGMP Manufacturing for Upcoming Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced completion of batch manufacturing of the DehydraTECH(TM)-processed cannabidiol (“CBD”) and placebo materials for its upcoming U.S. phase 1b hypertension clinical trial HYPER-H23-1. According to the update, Lexaria retained the services of a U.S. contract manufacturing organization to produce the materials compliant with current Good Manufacturing Practice (“cGMP”) regulations as mandated by the Food and Drug Administration (“FDA”). Filling into capsules is expected to be completed this month. This will follow with analytical release and stability testing in order to gather essential quality control data necessary for Lexaria’s upcoming Investigational New Drug (“IND”) filing to the FDA, as previously agreed upon in last year’s successful pre-IND meeting as announced on Aug. 10, 2022.

To view the full press release, visit https://cnw.fm/FBr8V

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 30 patents granted and many patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

BizCann Expo: An Elite Business & Networking Event for All Things Cannabis

BizCann Expo, a must-attend event for anyone working in the cannabis space, will be held in the city of Medellín, Columbia, May 20-21, 2023, a beautiful location surrounded by the spectacular Andes mountains. Colombia’s location an1d promising regulatory environment make it a rich location for the cannabis industry, with Medellin and nearby regions guiding its growth.

BizCann is the leading event in South and Latin America driving education, entrepreneurship, and innovation in all facets of the cannabis industry. Whether you’re a recognized canna-entrepreneur, or you are looking to join this exhilarating industry, BizCann Expo has all the resources you’ll need to connect to potential capitalists, find products, and launch your venture into a successful business.

BizCann Expo integrates the verticality of the cannabis industry, from seed to sale, in a safe space for entrepreneurship and learning. The expo welcomes plant-touching and non-plant-touching companies as well as ancillary services within the cannabis industry. The event lets the attendees showcase their business services, including innovative technologies and advanced products, to their potential customers and instantly make substantial gains. This event is for ages 18+ only.

Geared to ignite new business relationships

With 400+ exhibitors and a massive audience, the BizCann Expo is a must-visit event for all businesses hailing from the related industry verticals. This expo will focus on the prospects of the cannabis industry, and it attracts a wide range of participants, including business professionals, buyers, retailers, and end-users. They can avail amazing deals on the most popular CBD brands in the market.

The BizCann Expo will bring together the whole CBD and hemp business into one all-inclusive, comprehensive event, offering two days of seminars and workshops for attendees and industry professionals to learn about how cannabis improves health and wellness. Exhibitions will focus on the different cannabis benefits, and include the latest study on its use for treating different health conditions.

The BizCann Expo provides an opportunity to learn about the key elements of CBD and hemp from expert speakers. Licensed Producers, investors, growers, and suppliers can take advantage of networking opportunities and join like-minded industry professionals working in different aspects of the cannabis industry. It will help ensure their brands will prosper in the fast-growing cannabis business.

To learn more, please visit https://cnw.fm/jb0qM.

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Study Shows Marijuana Helps Cancer Patients Manage Pain

According to a recent Canadian study, medical marijuana may be able to lessen cancer patients’ dependence on other medications by easing their discomfort. The study, published in “BMF Palliative and Supportive Care,” involved the examination of 358 cancer patients and concluded that cannabis could be safely combined with other medications to help in pain management.

Every three months, the researchers checked on the patients to see how much pain they were in and how many medications they were taking. Patients reported substantially less pain after using the cannabis-based medications and that their pain had less of an impact on their daily lives.

According to the study, one-third of cancer patients — about 38% — experience medium-to-high-level pain even after taking pain medications such as opioids. In particular, 66% of patients with metastatic, advanced or terminal illnesses, as well as 55% of patients receiving anticancer treatment, experience pain.

Additionally, the majority of patients report feeling nauseous, drowsy, constipated and — more seriously — restrained breathing. For these reasons, patients are increasingly asking doctors, including up to 61.5% of general practitioners, to consider medical marijuana for the treatment of pain and other symptoms related to cancer.

In the study, 38% of the patients used THC-CBD-balanced medications, 17% used CBD-dominant medicines, and nearly a quarter of the patients used THC-dominant products. Those who consumed THC-CBD-balanced products experienced less pain compared to patients who only used THC- or CBD-dominant products.

However, the researchers noted that the results need to be confirmed by more thorough studies that compare the effects of cannabis-based medications with those of a placebo in a control group.

There is a lot of interest in cannabis’ ability to relieve pain, particularly in light of the opioid epidemic that has sparked concerns about the long-term dangers of opiate addiction. In support of this, a large body of research has demonstrated a correlation between decreased opioid prescribing and overdose fatalities and legalized marijuana use. A study by the University of Colorado published last month indicated that regular marijuana usage is linked to better cognition and less pain in chemotherapy and cancer patients. Researchers discovered that patients who consumed products with higher CBD levels experienced less pain than those who used high-THC goods.

According to research conducted by the American Medical Association (AMA) and released earlier this year, people with chronic pain who used medical cannabis for more than a month had their need for opioids significantly reduced. Late last year, the AMA also published studies showing a link between legalized cannabis in some states and reduced opioid prescriptions for some cancer patients.

This study highlighting the pain-fighting potential of marijuana suggests that companies that are working to develop THC-based medications for chronic pain, such as IGC Pharma Inc. (NYSE American: IGC), are likely to be successful in their R&D efforts.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Oregon Secretary of State Resigns Due to Cannabis Consultancy Job

Last week, Shemia Fagan resigned as Oregon Secretary of State after receiving significant criticism for taking up a job as a consultant to a cannabis company while her office was concluding an audit of the state’s Liquor and Cannabis Commission. During her announcement, Fagan apologized for working for the business, pointing out that while she had planned to finish her term, it had been an honor to serve the people of Oregon.

She also highlighted that ethics guidelines permitted outside employment, noting that consulting for La Mota wasn’t a conflict of interest as any actions taken on account of the audit would be by the cannabis commission, legislature or governor. Fagan added that any changes in regulation would have also affected many businesses, not just her client. However, she continued, she had exercised poor judgment by working with a business regulated by an entity under audit by her division.

The consulting job is said to have paid her $10,000 a month, with added bonuses for every license she assisted the affiliate of La Mota acquire outside Oregon.

The salary of the secretary of state stands at $77,000 per annum, a low sum, particularly for the office’s tasks, which include auditing state agencies and overseeing elections. Results of the audit, which were released the week before, demanded that the state’s cannabis regulatory agency make changes to some of the rules for cannabis businesses.

Fagan isn’t the first to resign or leave the secretary of state post in Oregon. In fact, two recent secretaries have vacated their four-year term — one because of a death in office and one because the governor resigned and was replaced by the secretary of state. A successor to Fagan will be appointed by Governor Tina Kotek, who stated that she supported Fagan’s decision to resign from her elected office.

Following Fagan’s resignation announcement, Democratic leaders in the legislature released a joint statement declaring that Fagan needed to go. Those leaders included Senate Majority Leader Kate Lieber, Senate President Rob Wagner, House Speaker Dan Rayfield and House Majority Leader Julie Fahey. The statement noted that Fagan’s serious lapses of judgment had destroyed trust with the residents of Oregon, including lawmakers who depended on the work of the Audits Division for important information on public policy. They observed that her resignation would allow the state to rebuild trust and move forward.

Prior to being elected to the position in 2020, Fagan served as a Democratic member of the Oregon Senate.

As the marijuana industry continues its growth trajectory and blips such as this one are avoided, more cultivators will join the space to meet the growing demand for marijuana. By extension, more cultivation equipment, such as the microgardens commercialized by enterprises such as Advanced Container Technologies Inc. (OTC: ACTX), will be sold and revenues earned.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lift 2023 Event to Return to the Heart of Downtown Toronto

Lift Events & Experiences, Canada’s No. 1 cannabis conference and trade show series, today announced its return to the Metro Toronto Convention Centre (“MTCC”), a top-of-class venue for business event organizers, located in the heart of downtown Toronto. Lift Toronto 2023, slated to take place on June 1-3, is expected to attract representatives from more than 150 companies within the cannabis-value chain, 140+ renowned industry thought leaders, and 3,000 to 5,000 growers, licensed producers, retailers, budtenders, investors and consumers. As a fifth year of cannabis legalization in Canada comes to fruition, the event will commence with the full-day Lift Cannabis Business Conference (“LCBC”). The country’s premier business strategy conference, LCBC features an ideal platform to connect industry peers with managerial leaders, innovators, regulators, investors, researchers, suppliers and professional services. The LCBC, through a host of strategy-focused, advocacy-oriented, truth-to-power, business and industry leadership sessions, will chart the next steps for an industry that is targeting sustainable growth at home and around the world.

To view the full press release, visit https://cnw.fm/n7WPT

About Lift Events & Experiences

Lift Events & Experiences, known for Canada’s number-one cannabis industry conferences and trade shows, is expanding across the continent. Dedicated to honoring the legacy of the cannabis industry, Lift welcomes everyone, from craft growers to multistate operators to everyday folks who enjoy and respect the plant. Lift Events & Experiences is proudly managed by MCI Events.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the results of the 2023 Annual Meeting. According to the update, the company held the meeting at 1:00 p.m. PT on May 9, 2023, whereby there were 3,372,024 shares of the company represented in person or by proxy, constituting 56.3% of the company’s issued share capital as of the meeting date of March 13, 2023. The matters voted upon and the final voting results are set forth as detailed in the announcement. All proposals are described in detail in Lexaria’s proxy statement filed with the Securities Exchange Commission via Edgar and with the BC Securities Commission and Ontario Securities Commission via SEDAR on March 22, 2023.

To view the full press release, visit https://cnw.fm/Zkl8k

About Lexaria Bioscience Corp.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

2023 Alternative Products Expo, Medellin, to Network and Expand Your Business in a Single Comprehensive Event

Professionals, retailers, distributors, and enthusiasts are invited to attend the one-of-a-kind Alternative Products Expo to be held in Medellin, Colombia, from May 20-21, 2023. It’s a uniquely all-inclusive event that brings together the multi-billion-dollar alternative products industry into one comprehensive setting.

Every mainstream product has an alternative counterpart. The Alternative Products Expo is the one-stop destination to meet the prominent counterculture manufacturers and take advantage of the latest innovations and trends, show discounts, and network in the industry. By bringing the alternative community together, the expo seeks to provide industry professionals with a unique and immersive opportunity for business expansion and networking.

The Alternative Products Expo will feature all the advanced products that are disrupting the traditional markets. This innovative business networking event has expanded its show to include a wider range of alternative products, such as dietary supplements, kratom, nootropics, mushrooms, vapes & nicotine replacements, hemp derivatives, energy beverages, and more.

The Largest Expo Of Hemp, Vape, and Counterculture

ALT PRO Expo redefines the tradeshow experience by including a unique vibe that makes this an exciting event for any adult audience. With a vibrant and fun atmosphere, this event is designed to provide an exciting experience to meet the leading counterculture manufacturers, discover new product innovations, get updated on industry trends, and find the best show-exclusive deals.

The event is the ultimate gathering for independent retailers, smoke shop owners, buyers, and counterculture enthusiasts. Increasingly known for its pleasant climate and warm people, Medellin is an evolving tourism and business hub boasting the perfect landscape and incredible vibe for companies to make an impact. Alternative Products Expo is a B2B and B2C networking event for disruptive industries such as hemp-derived products, non-psychoactive mushrooms, nutraceuticals, semi-synthetic extracts, functional beverages, delta8, kratom, nicotine alternatives, and many more.

Network with over 400 vendors bringing the industry’s best brands.
Learn from expert speakers sharing knowledge and industry insights.
Find exclusive opportunities to buy innovative products at special prices.
Discover innovative products which your business could take to a mainstream audience.

To learn more, please visit https://cnw.fm/1KlA8. and https://cnw.fm/zBCcZ.

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.